Neuropathy & Pain

Urinary incontinence is one of the most common yet least discussed complications of diabetes. In fact, diabetes urinary incontinence affects people with diabetes at significantly higher rates than the general population. While healthcare professionals routinely monitor patients for retinopathy, nephropathy, and cardiovascular disease, bladder dysfunction often remains overlooked. However, research …

Diabetes-related complications often bring to mind kidney disease, neuropathy, or vision problems. However, one complication continues to receive far less attention despite growing scientific concern: hearing loss linked to diabetes. Emerging evidence suggests that people with diabetes may face a significantly higher risk of hearing decline, yet routine auditory screening …

Cardiovascular outcomes often dominate discussions about GLP-1 receptor agonists, but what about nerve health? Growing interest in GLP-1 diabetic neuropathy reflects a broader shift toward understanding microvascular complications beyond heart disease. While medications such as semaglutide (Ozempic), dulaglutide (Trulicity), and liraglutide (Victoza) have proven cardiovascular benefits, their potential influence on …

Patients using GLP-1 receptor agonists are reporting something unexpected: less joint and musculoskeletal pain. As interest grows in how GLP-1 therapies may affect chronic pain, clinicians are asking an important question. Are these improvements simply the result of weight loss, or do GLP-1 medications have direct anti-inflammatory and neuromodulatory effects? …

Clinicians must inform patients about diabetic neuropathy risks, symptoms, and management to prevent complications and enhance quality of life.

There is not much evidence-based literature on point-of-care devices, yet they are commonly used for diagnosis. 

Patients experiencing pain along with their diabetic polyneuropathy are at an increased risk of vascular events and mortality.

Metformin has been associated with a higher incidence of peripheral neuropathy.

How often are opioids being initiated for diabetic peripheral neuropathy (DPN) in newly diagnosed patients?

As patients’ vitamin D levels rose, the pain and other symptoms of painful diabetic neuropathy decreased.